In March 2025, the company declared new plans for the direct-to-purchaser featuring of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which would cost customers $499 a month for access to the drug, below 50 % the cost of the drug by way of other pharmaceutical distribution networks.[53]Research of